Celltrion Healthcare Co.,Ltd.
ChangIn Chloe Lee currently serves as the Team Lead of the Marketing Planning Team at Celltrion Healthcare Co. Ltd, a position held since January 2024. Prior to this role, ChangIn held various positions at Celltrion Healthcare Co., Ltd. from November 2010 to December 2023, including Team Lead of the Marketing Planning & Licensing Team, Product Manager, and Assistant Manager in several capacities. Significant accomplishments include leading EU marketing initiatives as Southern Europe Part Leader, executing the launch of the first biosimilar product in Germany, and managing key opinion leader (KOL) relationships. ChangIn Lee holds a Bachelor of Science in Food Science & Technology and Business Administration from Korea University, completed in 2010.
This person is not in any offices
Celltrion Healthcare Co.,Ltd.
Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines through an extensive global network that spans more than 110 different countries. Celltrion Healthcare provides REMSIMA, the world's first biosimilar monoclonal antibody (mAb) approved by the European Medicines Agency (EMA) for the treatment of autoimmune disease, and innovative biopharmaceutical medications to help increase patient access to advanced therapies around the world. For additional information on our guidelines, please visit: https://bit.ly/3QyOyt7